2025年4月29日,药明生物(02269)根据2016年采纳并修订的首次公开发售前购股权计划,为行使期权发行400万股普通股。此举旨在落实公司激励机制,推动长远发展。相关股份已正式发行。免责声明:本文内容由开放的智能模型自动生成,仅供参考。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.